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Abstract
Apoptosis is a major cause of cell death in the nervous system. It plays a role in embryonic and early postnatal brain
development and contributes to the pathology of neurodegenerative diseases. Here, we report that activation of the P2X7
nucleotide receptor (P2X7R) in rat primary cortical neurons (rPCNs) causes biochemical (i.e., caspase activation) and
morphological (i.e., nuclear condensation and DNA fragmentation) changes characteristic of apoptotic cell death.
Caspase-3 activation and DNA fragmentation in rPCNs induced by the P2X7R agonist BzATP were inhibited by the
P2X7R antagonist oxidized ATP (oATP) or by pre-treatment of cells with P2X7R antisense oligonucleotide indicating a
direct involvement of the P2X7R in nucleotide-induced neuronal cell death. Moreover, Z-DEVD-FMK, a speciﬁc and
irreversible cell permeable inhibitor of caspase-3, prevented BzATP-induced apoptosis in rPCNs. In addition, a speciﬁc
caspase-8 inhibitor, Ac-IETD-CHO, signiﬁcantly attenuated BzATP-induced caspase-9 and caspase-3 activation,
suggesting that P2X7R-mediated apoptosis in rPCNs occurs primarily through an intrinsic caspase-8/9/3 activation
pathway. BzATP also induced the activation of C-jun N-terminal kinase 1 (JNK1) and extracellular signal-regulated
kinases (ERK1/2) in rPCNs, and pharmacological inhibition of either JNK1 or ERK1/2 signiﬁcantly reduced caspase
activation by BzATP. Taken together, these data indicate that extracellular nucleotides mediate neuronal apoptosis
through activation of P2X7Rs and their downstream signaling pathways involving JNK1, ERK and caspases 8/9/3.
Abbreviations: ATP – adenosine 50-triphosphate; BzATP–20-30-O-(4-benzoylbenzoyl)-ATP; [Ca
2+]i–intracellular free
calcium concentration; ERK–extracellular signal-regulated protein kinase; JNK–c-Jun NH2-terminal kinase; MAPK–
mitogen-activated protein kinase; oATP–oxidized ATP; P2Y2R–P2Y2 nucleotide receptor; P2X7R–P 2X 7 nucleotide
receptor; PBS–phosphate buffered saline; PKC–protein kinase C; rPCNs–rat primary cortical neurons; RT-PCR–reverse
transcriptase-polymerase chain reaction; SH3–Src-homology-3; Src–non-receptor tyrosine kinase; TNF-a –tumor necrosis
factor-a
Introduction
ATP is an important extracellular messenger generated
from various sources including release from presynaptic
vesicles upon nerve stimulation in the peripheral and cen-
tral nervous systems [1]. Extracellular ATP functions as a
neuromodulator by activation of cell surface P2 nucleotide
receptors that are widely expressed in the nervous system
[2, 3]. Based on their distinct structure, P2 nucleotide re-
ceptors are classiﬁed into two families: G protein-coupled
P2Y receptors (P2YR1,2,4,6,11Y14; 4) and ligand-gated ion
channels (P2XR1Y7; 5). Functional responses to activation
of these P2 receptor subtypes in cells of the nervous system
under normal and pathological conditions include cell
apoptosis, proliferation and migration, inﬂammation, ion
transport, and neurotransmission [5Y9]. Therefore, P2 re-
ceptors in the nervous system may prove to be useful phar-
maceuticaltargetsinthetreatmentofneurologicaldisorders.
The seven subtypes of the ionotropic ATP-gated P2XR
family, ranging from 379 to 595 amino acids in length,
regulate the intracellular calcium concentration through
ligand-stimulated increases in the cell membrane perme-
ability to extracellular Ca
2+ ions [10, 11]. In contrast to
other P2XRs, the P2X7R subtype functions exclusively as a
homomeric receptor [12, 13]. The P2X7R is a 595-amino
acid polypeptide containing two membrane-spanning do-
mains, a large extracellular loop, and intracellular N- and
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longest among the cloned P2XRs [14, 15]. P2X7Rs have
been reported in microglial cells [16] where they play a
role in cytokine release [17]. These receptors are also found
in cultured astrocytes and Schwann cells [18, 19], spinal
cord neurons and in other regions of the central nervous
system [20, 21]. Brief stimulation of the P2X7R with ATP
results in formation of a non-selective cationic channel that
promotes the inﬂux of Ca
2+ and the equilibration of the
transmembrane sodium and potassium gradients leading to
membrane depolarization [14, 15, 22, 23]. Subsequent re-
sponses to P2X7R activation include the formation of a
nonselective pore for molecules up to 900 Da [22, 23],
extensive membrane blebbing, and eventual cell death [23].
Activation of the P2X7R was reported to elicit Ca
2+ inﬂux
in cerebrocortical nerve terminals [24] and hippocampal
glutamate release [25], which has been conﬁrmed by stud-
ies with P2X7R knockout mice [26]. In an ex vivo model of
organotypic hippocampal cultures, P2X7R activation was
shown to directly participate in cell damage induced by
oxygen/glucose deprivation [27]. It has been shown that a
Pro-451 to Leu polymorphism within the C-terminal tail of
the P2X7R interferes with the ability of the receptor to
induce cell death in murine thymocytes [28]. The P2X7R
also has been shown to mediate ATP-induced cell death in
human embryonic kidney cells [29] and human cervical
epithelial cells [30]. A recent study demonstrated that spi-
nal cord injury was associated with prolonged P2X7R acti-
vation of spinal cord neurons by extracellular ATP, which
resulted in high-frequency spiking, increases in cytosolic
calcium levels and neuronal degeneration, responses that
were reversed by P2X7R inhibition [31].
In the present study, we demonstrate that the P2X7R
agonists BzATP or ATP induce nuclear condensation and
DNA fragmentation in rat primary cortical neurons
(rPCNs). These apoptotic responses in rPCNs were de-
pendent on the functional expression of P2X7Rs that
mediate the ERK1/2- and JNK1-dependent activation of
caspases-8/9/3.
Materials and methods
Materials
Fetal bovine serum (FBS) was obtained from Hyclone
(Logan, UT, USA). Dulbecco’s Modiﬁed Eagle’s medium
(DMEM), Minimum Essential Medium (MEM), Neuro-
basal medium, penicillin (100 units/ml), streptomycin (100
units/ml) and B27-AO (B27 without cortex antioxidants)
were obtained from Gibco-BRL (Carlsbad, CA, USA).
Rabbit anti-rat ERK1/2, horseradish peroxidase (HRP)-
conjugated goat anti-rabbit IgG, and HRP-conjugated goat
anti-mouse IgG antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Goat anti-rat
P2X7R antibody was obtained from Alomone (Jerusalem,
Israel). Rabbit anti-rat caspase-8 antibody was obtained
from Biovision Inc. (Mountain View, CA, USA). Mouse
anti-NeuN antibody was obtained from Chemicon Interna-
tional Inc. (Temecula, CA, USA). Alexa Fluor TM 488
goat anti-mouse IgG antibody, Alexa Fluor TM 594 goat
anti-rabbit IgG antibody, YO-PRO-1, TO-PRO-3 and the
Prolong
\ anti-fade kit were obtained from Molecular
Probes Inc. (Eugene, OR, USA). All other antibodies were
obtained from Cell Signaling Technology (Beverly, MA,
USA). Caspase-3 and caspase-9 inhibitors were obtained
from R&D (Minneapolis, MN, USA). Caspase-8 inhibitor
was obtained from BioSource International Inc. (Cama-
rillo, CA, USA). The Precision Plus Protein Standards and
nitrocellulose membranes (0.45 mm) were obtained from
Bio-Rad (Hercules, CA, USA). LumiGLO chemilumines-
cent substrates were obtained from New England Biolabs
(Beverly, MA, USA). The RNeasy Mini Kit was obtained
from Qiagen (Chatsworth, CA, USA). The Apoptotic
DNA-ladder kit, the First Strand cDNA Synthesis kit and
the TUNEL In Situ Cell Death Detection kit were obtained
from Roche (Indianapolis, IN, USA). Nucleotides and all
other biochemicals were obtained from Sigma Chemical
Co. (St. Louis, MO, USA).
Primary cell culture of cortical neurons
Experimental procedures for cell culture of rat primary cor-
tical neurons (rPCNs) were carried out essentially as de-
scribed by Suen et al. [32]. Brieﬂy, cerebral cortices from
18-day-old embryos of SpragueYDawley rats were removed
and the meninges discarded. The brain tissue was me-
chanically dissociated in HGGMEM comprised of 1.78 g
glucose, 100 IU/ml penicillin, 100 mg/ml streptomycin,
7.5 mg/ml fungizone, 2 mM glutamine in 88 ml of MEM
and 10% (v/v) horse serum. The tissue clumps were dis-
persed with a 10 ml pipette and suspended in 6 ml of
0.25% (w/v) trypsin at 37 -C for 10 min. After incubation,
2 ml of heat-inactivated horse serum were added to block
trypsin activity. Cells were centrifuged at 4000 g for 10 min
at 4 -C and the pellet was suspended in ice-cold
HGGMEM with 10% horse serum. The cell suspension
was ﬁltered through a sterilized 85 mm cell strainer (nylon
membrane; Becton Dickinson, Franklin Lakes, NJ) and
cells were counted and seeded into plastic culture plates
that were precoated with poly-D-lysine. After 16Y18 h and
every 2Y3 days thereafter, the medium was replaced with
B27-AO Neurobasal medium (2 mM glutamine, 8.9 g
glucose, 100 IU/ml penicillin, 100 mg/ml streptomycin, 7.5
mg/ml fungizone, 10 ml of B27 minus AO, and Neurobasal
medium (Gibco-BRL) to 500 ml) and the neurons were
ready for use after 7 days in culture.
RT-PCR analysis of P2XR mRNA expression
Total RNA was isolated from rPCNs using the RNeasy
Mini Kit (Qiagen). cDNA was synthesized from the
puriﬁed RNA using the First Strand cDNA Synthesis Kit
for RT-PCR (AMV) (Roche). Five percent of the synthe-
sized cDNA was used as a template in PCR reactions with
the Expand High Fidelity PCR System (Roche). Speciﬁc
338 Q. Kong et al.oligonucleotide primers were designed to selectively am-
plify cDNA for individual P2XR subtypes, as shown in
Table 1. The ampliﬁcation was performed using 35 cycles
of denaturation at 95 -C for 30 s, with annealing at 60 -C
for 30 s and extension at 72 -C for 1 min. The resulting PCR
products were resolved on a 1% (w/v) agarose gel contain-
ing 10 mg/ml ethidium bromide and photographed under
UV illumination.
Single cell calcium assay
The [Ca
2+]i was quantiﬁed in single cells with the Ca
2+-
sensitive ﬂuorescent dye fura-2, using an InCyt Dual-
Wavelength Fluorescence Imaging System (Intracellular
Imaging, Cincinnati, OH). Rat PCNs cultured on a poly-D-
lysine-coated coverslip were incubated with 2.5 mM fura-2-
acetoxymethylester at 37 -C for 30 min in physiological
salt solution (PSS) containing (mM) NaCl 138, KCl 5,
CaCl2 2, MgCl2 1, HEPES 10, glucose 10, pH 7.4, and
washed with PSS. The coverslip with fura-2-loaded cells
was positioned on the stage of an inverted epiﬂuorescence
microscope (Nikon; model TMD) and stimulated with ago-
nists at 37 -C, as described in the ﬁgure legends. Cells
were exposed to 340/380 nm light and ﬂuorescence emis-
sion at 505 nm was converted to [Ca
2+]i using a standard
curve created with solutions containing known concentra-
tions of Ca
2+. Increases in [Ca
2+]i were measured by sub-
tracting basal [Ca
2+]i from the maximum agonist-induced
increase in [Ca
2+]i. The percentage of cells that responded
to ATP/BzATP was also determined. Viable cells were
identiﬁed by responsiveness to carbachol and non-respond-
ing cells were eliminated.
Detection of nuclear condensation
Rat PCNs were cultured in B27-AO Neurobasal medium
on poly-D-lysine-coated coverslips in 12-well plates until
50Y70% conﬂuence. After nucleotide treatments, medium
was removed and cells were washed once and incubated
with DAPI-methanol staining solution (1 mg/ml) for 15 min
at 37 -C. The staining solution was removed and the cells
were washed with methanol. The inverted coverslip was
placed onto a microscope slide using glycerol as the
mounting agent. Nuclear morphology was observed under
a ﬂuorescence microscope (Nikon, Eclipse TE300) with a
340/380 nm excitation ﬁlter and a LP 430 nm barrier ﬁlter.
DAPI has an absorbance maximum at 340 nm and an
emission maximum at 488 nm in aqueous solution [33].
DNA laddering assay
Rat PCNs were cultured in B27-AO Neurobasal medium in
100 mm dishes to 70% conﬂuence, and incubated in serum-
free medium overnight with or without BzATP. Then,
rPCNs were treated for 2 h with 500 mMH 2O2 and DNA
was isolated using the Apoptotic DNA-ladder kit (Roche,
Indianapolis, IN) according to the manufacturer’s instruc-
tions. DNA also was isolated from lyophilized apoptotic
U937 cell lysate (provided with the DNA-ladder assay kit)
for use as a positive control. Brieﬂy, the medium was
replaced with 200 ml of PBS and 200 ml of binding buffer
(6 M guanidine-HCl, 10 mM urea, 10 mM TrisYHCl,
pH 4.4, 20% (v/v) Triton X-100). After 10 min at 15Y25
-C, 100 ml of isopropanol was added and the samples were
transferred to a ﬁlter tube and centrifuged for 1 min at
10,000 g (Spectrafuge 18 M, Labnet, Edison, NJ). The ﬂuid
in the collection tube was discarded and the upper ﬁlter
column was washed with 500 ml of washing buffer (20 mM
NaCl and 2 mM TrisYHCl, pH 7.5, 40% (v/v) ethanol)
followed by centrifugation twice for 1 min at 13,000 g.
After the residual washing buffer was removed, the DNA
was eluted with 200 ml of pre-warmed (70 -C) elution
buffer (10 mM Tris, pH 8.5). The concentration and purity
of the eluted DNA was determined by measuring the
optical density at 260 and 280 nm. DNA was electro-
phoresed in a 2% (w/v) agarose gel at 80 V for 1 h in TBE
buffer (89 mM Tris base, 89 mM boric acid, 2 mM EDTA-
Na2-salt, pH 8.3) and visualized under UV light.
TUNEL assay
After treatment with nucleotides or H2O2, rPCNs were
ﬁxed with fresh 4% (v/v) paraformaldehyde in PBS and
treated with 3% (v/v) H2O2 in methanol to inhibit endog-
enous peroxidase activity. Then, DNA strand breaks in
ﬁxed cells were detected with a TUNEL In Situ Cell Death
Detection kit (Roche) according to the manufacturer’s in-
structions. The number of TUNEL-positive cells and the
total cell number were determined by ﬂuorescence (Nikon,
Eclipse TE300) using an excitation wavelength in the
range of 450Y500 nm and a detection wavelength in the
Table 1. Sequence-speciﬁc oligonucleotide primers used for RT-PCR
studies.
Receptor
subtypes
Oligonucleotide sequences
P2X1
Forward 50-AAC AGC ATC AGC TTT CCA CG-30
Reverse 50-TGT AGT AGT GCC TCT TAG GC-30
P2X2
Forward 50-ACC TGC CTC TCC GAC GCC GA-30
Reverse 50-GAA GTC AGA GCT GTG GCC AG-30
P2X3
Forward 50-CAA CTT CAG GTT TGC CAA A-30
Reverse 50-TGA ACA GTG AGG GCC TAG AT-30
P2X4
Forward 50-TAC GAC ACG CCG CGC ATC-30
Reverse 50-TGC ACG ATT TGA GGT AGG ACG-30
P2X5
Forward 50-CAA AGT CCA TGC CAA CGG AT-30
Reverse 50-ACG GAA CTC TAC CCC ATT AG-30
P2X6
Forward 50-GTA GTG CTG TGC CCA GGA AA-30
Reverse 50-GGA CTC CAC GCC TGA GGC TG-30
P2X7
Forward 50-ACA ATG TTG AGA AAC GGA CTC TGA-30
Reverse 50-CCG GCT GTT GGT GGA ATC CAC ATC-30
G3PDH
Forward 50-TGA AGG TCG GTG TCA ACG GAT TTG GC-30
Reverse 50-CAT GTA GGC CAT GAG GTC CAC CAC-30
P2X7R-mediated apoptosis in cortical neurons 339range of 515Y565 nm (green) and light microscopy with
cell counting, respectively, at 200  magniﬁcation.
Application of P2X7 antisense oligonucleotide
Antisense oligonucleotide treatment was performed as pre-
viously described [65]. Phosphorothioate-modiﬁed oligo-
nucleotides to rat P2X7 were synthesized and puriﬁed by
Integrated DNA Technologies (ADT, Coralville, IA, USA).
Sequences were designed as follows: sense 50-AGAGCGT
GAATTACGGCACATCAA-30, antisense 50-TTGATGGT
GCCGTAATTCACGCTCT-30. Sequences were checked
for uniqueness with the National Center for Biotechnology
Information’s Basic Local Alignment Search Tool [34]. The
rPCNs were incubated with 0.1 or 1 mmol/L P2X7 sense or
antisense S-oligonucleotide for 6 h in serum-free medium
containing 1.4% (v/v) DOTAP liposomal reagent (Roche
Diagnostics). Fresh serum-free medium was added with or
without BzATP, and cells were cultured for an additional
18 h.
Western blot analysis
Rat PCNs cultured in 6-well plates were treated with
300 mM BzATP in the presence or absence of inhibitors as
indicated. The cells were washed twice with ice-cold PBS,
and lysed for 5 min in 200 ml of ice-cold lysis buffer
(20 mM TrisYHCl, pH 7.5, 2% (w/v) sodium dodecyl
sulfate (SDS), and 1 mM sodium orthovanadate). Lysate
(30 mg of protein) was added to Laemmli sample buffer
(187.5 mM TrisYHCl, pH 6.8, 6% (w/v) SDS, 1.8% (v/v)
b-mercaptoethanol and 0.003% (w/v) bromophenol blue).
Samples were heated for 5 min at 96Y100 -C, and subjected
to 7.5% (w/v) SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to nitrocellulose membranes
for protein immunoblotting. After overnight blocking at
4 -C with 5% (w/v) fat-free milk in TBS-T (10 mM
TrisYHCl, pH 7.4, 120 mM NaCl, and 0.1% (v/v) Tween-
20), membranes were incubated with either 1:1000 dilution
of anti-ERK1/2, anti-phospho-ERK1/2, anti-phospho-JNK,
or anti-P2X7R antibodies for 2 h at room temperature, or
1:1000 dilution of anti-cleaved caspase-3, anti-caspase-3,
anti-cleaved caspase-9, anti-caspase-9, or anti-caspase-
8 antibodies overnight at 4 -C followed by incubation with
HRP-conjugated anti-rabbit or anti-mouse IgG antibodies
(1:1000 dilution in TBS-T containing 5% (w/v) fat-free
milk) for 1 h at room temperature. For normalization of
protein loading, the membranes were stripped of antibodies
by incubation for 30 min at 60 -C in stripping buffer
(62.5 mM TrisYHCl, pH 6.8, 100 mM 2-mercaptoethanol,
and 2% (w/v) SDS), and re-probed with 1:2000 dilution of
rabbit polyclonal anti-actin antibody (2 h at room temper-
ature; Cytoskeleton, Denver, CO) followed by 1:2000
dilution of HRP-conjugated anti-rabbit IgG antibody (1 h
Figure 1. Purity of rat primary cortical neurons (rPCNs) and P2X7R expression. (A) Rat PCNs were cultured on coverslips in 6-well plates and neurons
were labeled with mouse NeuN monoclonal antibody (Panel a) and cell nuclei with TO-PRO-3 (Panel b); merged picture shown in Panel c. (B) RNA
was isolated from rPCNs maintained in culture for 7Y10 days and RT-PCR was used to amplify mRNAs to P2X1Y7Rs, as described in the Materials and
methods. The ampliﬁed PCR products were resolved by gel electrophoresis, and data shown are representative of results from three independent
experiments. Results are shown of PCRs performed in the presence (+) or absence (j) of reverse transcriptase (RT). G3PDH primers were used to
amplify G3PDH mRNA as a positive control. (C) P2X7R protein expression was detected by Western blot analysis, as described in the Materials and
methods. Human 1321N1 cells expressing the recombinant human P2X7R or the empty expression vector pLXSN were used as positive (+) or negative
(j) controls, respectively. Precision Plus Protein Standards are indicated as F75KD_ and F100KD._
340 Q. Kong et al.at room temperature). Protein immunoreactivity was
visualized on autoradiographic ﬁlm using the LumiGlo
Chemiluminescence System (New England BioLabs),
according to the manufacturer’s instructions. The protein
bands detected on X-ray ﬁlm were quantiﬁed using a
computer-driven scanner and Quantity One software (Bio-
Rad, Hercules, CA). The activation levels of kinases or
caspases were calculated as a percentage of control (i.e.,
total kinase, caspase, or actin).
Immunoﬂuorescence
After ﬁxation and permeabilization, rPCNs cultured on
coverslips in 6-well plates were incubated in 2.5% (w/v)
BSA and 2.5% (v/v) goat serum in PBS for 1 h at room
temperature followed by incubation overnight with mouse
anti-NeuN antibody (1:100 dilution; Chemicon) and rabbit
anti-cleaved caspase-3 antibody (1:100 dilution; Cell
Signaling) in 0.25% BSA and 0.25% goat serum in PBS.
Cells were washed three times with PBS and then
incubated with 1:200 dilution of goat anti-mouse Alexa
Fluor 488- or goat anti-rabbit Alexa Fluor 594-conjugated
IgG antibody (Molecular Probes, Eugene, OR) in 0.25%
BSA and 0.25% goat serum in PBS for 1 h at 37 -C. Nuclei
were stained with TO-PRO-3 (Molecular Probes), cells
were rinsed with PBS and mounted on glass slides in
a
Figure 2. ATP- and BzATP-induced increases in [Ca
2+]i in rat PCNs. (A)
Single cell calcium assays were performed on rPCNs that were cultured
for 7Y10 days on poly-D-lysine-coated coverslips. Fura-2 loaded cells
were incubated in PSS with the indicated concentration of BzATP or ATP
and the maximum increase in [Ca
2+]i was determined, as described in the
Materials and methods. (B) The percentage of cells responding to BzATP
or ATP is shown as the mean T S.E.M. of results from three experiments.
Figure 3. ATP/BzATP-induced nuclear condensation mediated by the
P2X7R is dependent on caspase-3 activation. (A) Rat PCNs were cultured
for 7Y10 days, incubated in serum-free HGGMEM for 6 h and stimulated
with BzATP (300 mM) or ATP (100 mM) for 16 h or with H2O2 (1 mM)
for 2 h. When indicated, 500 mM oATP was added 2 h prior to addition of
BzATP. Cells cultured in B27-AO Neurobasal medium (NB) or in serum-
free HGGMEM (j) overnight were used as controls. Then, nuclear
condensation was determined by DAPI staining and detected by
ﬂuorescence microscopy, as described in the Materials and methods. (B)
Cells were treated as in (A) except that the data were expressed as a
percentage of cells that exhibited DAPI stained nuclei. Data are the means
T S.E.M. of results from at least four experiments, where *P G 0.05, and
***P G 0.001 indicate signiﬁcant differences from the serum-starved
control (j), and where
###P G 0.001 indicates a signiﬁcant difference from
BzATP treatment. (C) rPCNs were treated as in (A) except that 10 mMZ -
DEVD-FMK, a caspase-3 inhibitor, was added for 1 h prior to BzATP,
when indicated.
P2X7R-mediated apoptosis in cortical neurons 341ProLong antifade reagent (Molecular Probes). Images were
obtained on a Bio-Rad MRC 1024 laser scanning confocal
imaging system coupled to an Olympus IX70 inverted
microscope. The imaging system was controlled by Laser
Sharp software (version 3.2; Bio-Rad, Hercules, CA).
Alexa 488-labeled slices were excited by 488 nm laser
light, and images were acquired with a 522 nm emission
ﬁlter with a bandwidth of 35 nm, whereas Alexa 594-
labeled slices were excited by 568 nm light and images
acquired with a 585 nm longpass emission ﬁlter. Settings
of the confocal microscope were optimized for imaging in
an initial experiment and then equivalently applied to all
sections. Laser power and photomultiplier tube (PMT) gain
were adjusted to ensure that even the brightest ﬂuorescence
was below saturation levels. Neurons were randomly
chosen and scanned at 512   512 pixel resolution.
Statistical analysis
Results are expressed as the means T S.E.M. Statistical
analysis of data was performed using Graph Pad Prism
version 4.0. Statistical signiﬁcance was determined by one-
way ANOVA between groups followed by post hoc
NewmanYKeuls test. Differences were considered statisti-
cally signiﬁcant when P G 0.05.
Results
Purity of rat cortical neurons in primary culture
The purity of cultured rat primary neurons was determined
by monitoring morphology with phase contrast microscopy
and by immunoﬂuorescence assay with the neuron-speciﬁc
marker NeuN and the nuclear stain, TO-PRO-3 (Figure 1A).
NeuN staining was found primarily in the nucleus of the
neurons with lighter staining in the cytoplasm. About 95%
of the cells were determined to be cortical neurons based
on the ratio of NeuN positive cells to total cells counted by
TO-PRO nuclear staining (data not shown).
Functional P2X7Rs are expressed in rat PCNs
Rat PCNs express P2X7R mRNA, as well as mRNAs for
P2X2,P 2 X 3,P 2 X 5,a n dP 2 X 6 receptors (Figure 1B). Fur-
thermore, immunoblot analysis indicated that rPCNs express
P2X7R protein (Figure 1C). The P2X7R agonists ATP and
BzATP (35) caused a dose-dependent increase in [Ca
2+]i in
rPCNs (Figure 2), suggesting that calcium inﬂux is stimu-
lated by activation of the endogenously expressed P2X7R
protein. Calcium responses were also observed by stimula-
tion of rPCNs with 2-methylthio-ADP (data not shown), an
agonist of the P2Y1R, indicating that other P2R subtypes
besides the P2X7R can regulate increases in [Ca
2+]i.
ATP and BzATP induce nuclear condensation and DNA
fragmentation in rPCNs
Treatment of rPCNs with either BzATP (300 mM) or ATP
(100 mM) overnight caused nuclear condensation as in-
dicated by increased DAPI staining of nuclei (Figure 3).
BzATP-induced nuclear condensation was inhibited by the
P2X7R antagonist oATP, consistent with the involvement
of P2X7Rs in this process. Moreover, BzATP treatment of
rPCNs caused DNA fragmentation, suggestive of apoptotic
cell death (Figure 4). BzATP or ATP also caused DNA
strand breakage in rPCNs, another indicator of apoptosis,
detected as an increase in the number of TUNEL-positive
cells (Figure 5). These data suggest that BzATP or ATP
can cause apoptosis in rPCNs through a pathway involving
P2X7R activation.
P2X7R-mediated caspase-3 and caspase-9 activation
Caspase-3 is an essential component of apoptotic pathways
in many cell types, including neurons [36], and is activated
by the sequential release of cytochrome c from mitochon-
Figure 4. BzATP stimulates DNA fragmentation in rat PCNs. Rat PCNs
were incubated in serum-free HGGMEM for 6 h and then stimulated with
BzATP(300mM)for16horH2O2 (1 mM) for 2 h. Cells cultured in serum-
free HGGMEM (j) overnight were used as the control. Then, cells were
lysed, total DNA was puriﬁed, the DNA concentration was determined,
and 3 mg of puriﬁed DNA were loaded onto each lane of a 2% (w/v) aga-
rose gel and electrophoresed, as described in the Materials and methods.
DNAfragmentationwasvisualizedafterelectrophoresisofDNA.Apoptotic
U937 cells (+++; provided in the Apoptotic DNA-ladder kit) were used as a
positive control and FM_ indicates the 100 bp DNA ladder marker.
Figure 5. BzATP or ATP induces DNA strand breakage in rat PCNs. Rat
PCNs were cultured for 7Y10 days, incubated in serum-free HGGMEM for
6 h, and stimulated with BzATP (300 mM) or ATP (100 mM) for 16 h or
with H2O2 for 2 h. Cells cultured in serum-free HGGMEM (j) overnight
were used as the control. Then, cells were ﬁxed and DNA strand breakage
was determined by TUNEL assay, as described in the Materials and
methods. DNA strand breakage was observed as green ﬂuorescence using
ﬂuorescence microscopy.
342 Q. Kong et al.dria and the activation of caspase-9 [37]. Consistent with a
role for caspase-3 in nucleotide-induced neuronal apopto-
sis, nuclear condensation caused by BzATP was dimin-
ished by treatment of rPCNs with the caspase-3 inhibitor
Z-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-FMK (Z-DEVD-
FMK; Figure 3C). Results also indicated that treatment of
rPCNs with either ATP or BzATP signiﬁcantly increased
the cleavage of caspase-3 in a time- and dose-dependent
manner (Figure 6A). BzATP-induced caspase-3 cleavage
was inhibited by oATP (Figure 6B), the caspase-3 inhibitor
Z-DEVD-FMK (Figure 6B), or P2X7 antisense oligonucle-
otide (Figure 6C). Although recent studies indicate that
oATP might act independently from P2 receptor inhibition
[38], inhibition of BzATP-induced caspase-3 cleavage by
P2X7R antisense oligonucleotide conﬁrms the involvement
of the P2X7R. Since no preparation of primary neurons is
devoid of glial cells, dual immunoﬂuorescence analysis for
neuron-speciﬁc NeuN and cleaved caspase-3 was perfor-
med to evaluate whether the apoptotic cells were neurons.
The majority of cells treated with BzATP were positive for
cleaved caspase-3 and NeuN (e.g., pink and white arrows
in Figure 6D), indicating that a large percentage of cells
undergoing apoptosis were neurons. NeuN immunoreac-
tivity has been reported to decrease under several
pathological conditions [39], and therefore NeuN detection
may decrease with caspase-3 activation in apoptotic
neurons, suggesting that some apoptotic neurons may go
undetected.
BzATPalsocausedthecleavageofcaspase-9(Figure7A),
whereas activation of caspase-9 and caspase-3 were signif-
icantly inhibited by the caspase-8 inhibitor Ac-IETD-CHO
(Figure 7B) or the caspase-9 inhibitor Z-LEHD-FMK (data
Figure 6. P2X7Rs mediate caspase-3 activation in rat PCNs. (A) Rat PCNs were incubated in serum-free HGGMEM for 6 h and then the indicated
concentration of ATP or BzATP was added for 16 h or the time indicated. Cells cultured in serum-free HGGMEM (j) overnight were used as controls.
(B) Cells were treated as in (A) except that 500 mM oATP was added for 2 h or the indicated concentration (1, 10 or 100 mM) of Z-DEVD-FMK was
added for 1 h prior to addition of 300 mM BzATP for 16 h. (C) Cells were treated as in (A) except that P2X7 antisense or sense oligonucleotide was
added at the indicated concentration in mg/ml for 8 h prior to addition of 300 mM BzATP for 16 h or 1 mM H2O2 for 2 h. Western analysis was
performed as described in Materials and methods to determine the relative amounts of full length pan caspase-3, cleaved caspase-3 or P2X7R protein.
Data are the means T S.E.M. of results from at least three experiments, where *P G 0.05, **P G 0.01, and ***P G 0.001 indicate signiﬁcant differences
from BzATP-treated (B, C) cells. (D) Rat PCNs were serum-starved overnight in the presence (Panels B, D and F) or absence (Panels A, C, and E)o f
300 mM BzATP and then immunoﬂuorescence of the neuron-speciﬁc marker NeuN (green; Panels A, B), cleaved caspase-3 (red; Panels C and D), and
the nuclear stain TO-PRO (blue; Panels E and F) were detected as described in the Materials and methods. Arrows ( pink or white) indicate apoptotic
neurons that are both caspase-3 and NeuN positive, whereas yellow arrows indicate apoptosis in a NeuN-negative cell. Similar results were obtained in
three individually isolated groups of cells.
P2X7R-mediated apoptosis in cortical neurons 343not shown), indicating that caspase-8 also plays a role in
activating downstream caspase family members (i.e., cas-
pase-9/3) of the P2X7R-mediated apoptosis pathway. We
also detected an inhibitory effect of the caspase-9 inhibitor,
Z-LEHD-FMK, on caspase-8 cleavage (Figure 7C) sug-
gesting that caspase-8 and caspase-9 may regulate caspase-
3 activity in a non-linear fashion.
Caspase-3 activation by BzATP in rPCNs is dependent
upon ERK1/2 or JNK1 phosphorylation
P2X7R-mediated activation of extracellular signal-regulat-
ed kinases (ERK1/2) in rat primary astrocytes [40] and
Figure 7. Role of caspase-8 and caspase-9 in P2X7R-mediated apoptosis
in rPCNs. (A) Rat PCNs were incubated in serum-free HGGMEM and
BzATP (300 mM) was added for 16 h. Cells cultured in B27-AO
Neurobasal medium (NB) or in serum-free HGGMEM (j) overnight
were used as controls. (B) Cells were treated as in (A) except that the
indicated concentration (mM) of a speciﬁc caspase-8 inhibitor, Ac-IETD-
CHO was added for 1 h prior to addition of 300 mM BzATP. (C) Cells
were treated as in (B) except that the indicated concentration of a speciﬁc
caspase-9 inhibitor, Z-LEHD-FMK, was added. FPan_ ( full-length) and
cleaved caspase-8 were detected by Western analysis, as described in the
Materials and methods. Data are the means T S.E.M. of results from at
least three experiments, where *P G 0.05, **P G 0.01, and ***P G 0.001
indicate signiﬁcant differences from either serum-starved (A) or BzATP-
treated (B, C) cells.
Figure 8. BzATP or ATP induces ERK1/2 and JNK1 phosphorylation in
rPCNs. Rat PCNs were incubated in serum-free HGGMEM for 6 h and
treated with the indicated concentration (mM) of BzATP or ATP for 5 min
or with 100 mM ATP or 300 mM BzATP for the indicated time period.
Cells cultured in serum-free HGGMEM (j) overnight were used as the
control. Then, cell lysates were prepared and (A) ERK1/2 or (B) JNK1
phosphorylation was detected by Western analysis, as described in the
Materials and methods. Total ERK1/2 and actin were used as protein
loading controls for (A) and (B), respectively.
Figure 9. Inhibitors of MEK and JNK decrease BzATP-induced caspase-
3 cleavage in rat PCNs. Rat PCNs were incubated in serum-free
HGGMEM for 6 h and treated for 30 min with the indicated concentration
(mM) of (A) the MEK inhibitor U0126, (B) the JNK inhibitor SP600125 or
(A, B) 0.1% (v/v) DMSO as a vehicle control. Then, the cells were
incubated with 300 mM BzATP for 16 h, and Western analysis was used to
detect cleaved or pan caspase-3, as described in the Materials and
methods. Cells cultured in serum-free HGGMEM (j) overnight were used
as the control. Data are the means T S.E.M. of results from at least three
experiments, where *P G 0.05, **P G 0.01, and ***P G 0.001 indicate
signiﬁcant differences from BzATP-treated cells.
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independently of the activation of caspase-1- or caspase-
3-like proteases [41]. Here, we tested whether ERK1/2 or
JNK1 activities were involved in BzATP-induced apopto-
sis in rPCNs. As indicated in Figure 8, both ERK1/2 and
JNK1 were rapidly phosphorylated in response to BzATP
or ATP in a dose- and time-dependent manner. Inhibition
of ERK1/2 or JNK1 phosphorylation in rPCNs with either
the MEK inhibitor UO126 or the JNK inhibitor SP600125,
respectively, attenuated caspase-3 activation, indicating the
involvement of ERK1/2 and JNK1 in BzATP-induced
neuronal cell death (Figure 9).
Discussion
The results obtained with rat PCNs indicate that activation
of the P2X7R by its agonists BzATP or ATP promotes the
cleavage of caspases-8/9/3 and the appearance of cellular
markers indicative of apoptosis including DNA degrada-
tion and nuclear condensation and fragmentation. Since
BzATP can activate other P2X receptor subtypes, albeit at
higher concentrations than the P2X7R [42], we explored
the role of the P2X7R in the apoptotic effects of BzATP in
rPCNs using P2X7 antisense oligonucleotide to down-
regulate P2X7R expression and the P2X7R antagonist
oATP. Results indicate that inhibition of P2X7R activity
signiﬁcantly inhibited BzATP-induced nuclear condensa-
tion (by P2X7R antagonist oATP; Figure 3) and caspase-3
cleavage (by both oATP and P2X7R antisense oligonucle-
otide; Figure 6), apoptotic responses that were diminished
by incubation of rPCNs with the caspase-3 inhibitor,
Z-DEVD-FMK (Figures 3C and 6B). These data strongly
suggest that P2X7Rs mediate BzATP-induced apoptosis in
rPCNs, although this does not rule out a potential role for
other P2 nucleotide receptors.
P2X7R-mediated neuronal apoptosis in vivo requires that
ATP be released from neurons or non-neuronal cells to
activate cell surface receptors on neighboring neurons.
Neuronal P2X7 receptors are targeted to presynaptic termi-
nals in the central and peripheral nervous systems and
activation of the P2X7R has been indicated to promote
release of vesicular contents from presynaptic terminals
[20]. ATP is present at high concentrations in synaptic
vesicles and is released as a co-transmitter with noradrena-
line, acetylcholine and other neurotransmitters [1]. ATP
release also has been demonstrated in a model of spinal cord
injury [43]. Thus, ATP release from excited neurons or
damaged cells is an assumed consequence of any brain injury
or disease (e.g., ischemia, spinal cord injury, or neurodegen-
erative diseases), suggesting that pro-apoptotic P2X7Rs are
likely activated under pathological conditions in vivo.
Recent research indicates a lack of P2X7Re x p r e s s i o ni n
adult rat hippocampal neurons [44], whereas our studies
demonstrate functional P2X7Re x p r e s s i o ni nr P C N s
from 18-day old embryos. We have detected P2X7Rm R N A
in freshly isolated rPCNs (data not shown) and 7Y10 day-old
cultures (Figure 1), suggesting that the in vitro cell culture
procedure alone was not required for P2X7Re x p r e s s i o n .
Caspase activation is known to play a central role in the
execution of apoptosis by causing nuclear condensation,
DNA fragmentation and other apoptotic changes. In the
mitochondrial-initiated pathway of apoptosis, caspase
activation is triggered by the formation of a multimeric
Apaf-1/cytochrome c complex that is fully functional in
recruiting and activating procaspase-9 [37]. Activated
caspase-9 will then cleave and activate downstream
caspases such as caspase-3, -6, and -7. In rPCNs, it was
not surprising that activation of caspase-3 was signiﬁcantly
inhibited by the caspase-9 inhibitor Z-LEHD-FMK (data
not shown), since caspase-9 is known to activate caspase-3.
We also found that in rat PCNs, the caspase-8 inhibitor
Ac-IETD-CHO partially inhibited caspase-9 and caspase-3
activation (Figure 7B) indicating that caspase-8 cleavage
may be an early event in this neuronal apoptosis pathway.
Caspase-8 has been reported to play a role in cytochrome
c-dependent apoptosis [45] and caspase-8 activation is
associated with Fas receptor-induced apoptosis [46] and
can result in the cleavage and activation of Bid, a pro-
apoptotic member of the Bcl-2 family [47]. Truncated Bid
translocates from the cytoplasm to the mitochondria, where
it appears to antagonize the actions of anti-apoptotic Bcl-2,
thereby causing an efﬂux of cytochrome c from the mito-
chondria and downstream caspase-9/3 activation [47Y51].
In human embryonic kidney (HEK) 293 cells expressing
P2X7Rs, extracellular ATP induced apoptosis associated
with activation of poly (ADP-ribose) polymerase (PARP)
and a decrease in Bax protein expression [29]. We exam-
ined the effect of ATP/BzATP on the expression of Bcl-2
family members in rPCNs but failed to detect a signiﬁcant
change in Bax and Bcl-2 protein expression (data not
shown). Evidence from cell-free and in vitro expression
systems has indicated that caspase-3 can induce cleavage
and activation of the upstream initiator caspase-8 [52Y54].
Our data indicated that inhibition of caspase-9 cleavage
decreased caspase-8 cleavage (Figure 7C), consistent with
the ability of downstream caspases to regulate the cleavage
of initiator caspases.
We have demonstrated that activation of P2X7Rs in
rPCNs increases calcium inﬂux (Figure 2) and stimulates
phosphorylation of the intracellular kinases ERK1/2 and
JNK1 (Figure 8). Furthermore, inhibition of ERK1/2 or
JNK1 phosphorylation decreased BzATP-induced cas-
pase-3 cleavage (Figure 9). Our previous studies demon-
strating that P2X7R-mediated ERK1/2 activation was
dependent on extracellular Ca
2+ [55] suggest a similar
role for BzATP-stimulated calcium inﬂux in rPCNs
(Figure 2). Recent studies indicate that activation of
ERK and phosphatidylinositol 3-kinase/Akt signaling
pathways caused inhibition of caspase-3 and cell apoptosis
[56]. It also has been reported that inhibition of MEK/
ERK signaling is required for the induction of apoptosis
by Sulindac metabolites [57]. Nonetheless, our data sup-
port the hypothesis that ERK1/2 and JNK1 activation can
promote P2X7R-mediated apoptosis in rPCNs, although
the mechanism involved requires further investigation.
P2X7Rs can promote neuronal cell death by mediating
the release of glutamate and inﬂammatory factors from
P2X7R-mediated apoptosis in cortical neurons 345cells including astrocytes [18, 58, 59]. Moreover, gluta-
mate can induce ATP release from astrocytes [60],
suggesting that ATP and glutamate have reciprocal roles
that contribute to the propagation of an apoptotic signal. It
also has been reported that the P2X7R modulates macro-
phage production of TNF-a, IL-1b and nitric oxide (NO)
following LPS exposure [58], consistent with a role for the
P2X7R in inﬂammation [61]. In addition to these factors,
structural features within the P2X7R indicate that the
mechanism whereby it regulates apoptosis is likely to be
complex. There are several functional domains located in
the P2X7R C-terminal tail including an LPS-binding
domain, a SH3-binding domain, and an overlapping Fcell-
death_ domain, which appear to be important for receptor
trafﬁcking and various physiological functions [62], and
the role of these domains in P2X7R-mediated apoptosis of
neurons warrants further investigation. Our studies with the
membrane impermeant ﬂuorescent dye YO-PRO-1 (mo-
lecular weight: 375 Da) indicate that BzATP causes pore
formation (YO-PRO-1 uptake) in rPCNs (data not shown),
consistent with the report that apoptosis in the retinal
microvasculature is associated with P2X7 receptor-mediat-
ed pore formation [63].
A recent study indicated that spinal cord neurons ex-
pressed an abundance of P2X7Rs, and exposure of freshly
prepared spinal cord slices to ATP or BzATP evoked high-
frequency ﬁring and irreversible increases in the cytosolic
Ca
2+ concentration [31]. Signiﬁcant cell death occurred
24 h after spinal cord injury in areas of high ATP release
surrounding the epicenter of the injury, while local in-
jection of oATP in the peritraumatic zone strongly reduced
both apoptotic cell number and the severity of histological
injury, suggesting the involvement of a P2X7R. Other
studies indicate that the P2X7R is up-regulated in a mouse
model of Alzheimer’s disease [64]. Thus, the P2X7R may
represent a promising therapeutic target to inhibit neuro-
degeneration due to injury or disease.
In summary, the data presented indicate that BzATP and
ATPcanstimulateP2X7Rs in embryonic rat primary cortical
neurons leading to the activation of the caspases-8/9/3 and
the induction of DNA degradation and nuclear condensation
and fragmentation, apoptotic responses that appear to be
regulated by ERK1/2 and JNK1. Since neuronal apoptosis
occurs in Alzheimer’s disease, Parkinson’s disease and other
neurodegenerative disorders, a better understanding of the
mechanisms of P2X7R-mediated apoptosis may lead to
novel therapies to prevent apoptosis-related brain injuries.
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